In the next generation of DNA sequencing, routine DNA analysis in the clinical setting is not far off.
But Applied Bio lost most of the DNA sequencing market first to 454 Life Sciences, now owned by Roche, and then to Illumina of San Diego, which has become the dominant player in the DNA sequencing field.
FORBES: What Does This $14 Billion Deal Mean For The Future Of DNA Sequencing?
This is thanks first to the DNA sequencing technology introduced by 454 Life Sciences (now part of Roche), and then to the even faster, cheaper technology introduced by Illumina, which is now the dominant maker of DNA sequencing gear.
FORBES: Government Unveils First Map Of All The Germs In The Human Body
They were analyzed with advanced versions of the DNA-sequencing machines used to map DNA in the Human Genome Project.
His company Cofactor Bio offers a sequencing service to complement its GeneLaser DNA Sequencing Kit, which includes reagents for amplifying target sequences, and DNA Barcoding Kit, for identifying the biological origin of samples (available in editions for fish, fungi, flower plants, and other organisms).
FORBES: DNA Sequencing For Fun And Profit: A Low-Cost Platform For Garage Biotech
Several more cases of using DNA sequencing, which reads out the 6 billion DNA letters that contain the protein recipes that make one person different from another, to understand the cause of disease have been published.
FORBES: Sequencing A Child's DNA -- And Convincing An Insurance Company To Pay
But as the cost of DNA sequencing dropped, Knome found its business focused more on researchers who wanted help analyzing DNA samples.
Just today, Life Technologies announced that it is expects to increase the speed of its smaller, cheaper DNA 10-fold in just six months, illustrating how a war between makers of DNA-sequencing gear is driving the science behind this type of research.
It could treat DNA sequencing like genetic tests and require separate approvals for each use.
It slowly dawned on Rothberg that a sensor like that could be used for DNA sequencing.
The DNA sequencing and the data analysis will be compliant with regulations for lab diagnostics.
Each sample is catalogued and photographed before extracts are run through a DNA sequencing process.
To do so, it uses the DNA sequencing machines made by Illumina and other companies.
As a result of all of this competition and new technologies, DNA sequencing has gotten cheaper with incredible speed.
FORBES: What Does This $14 Billion Deal Mean For The Future Of DNA Sequencing?
Even with such an approval, there are pretty big regulatory and reimbursement hurdles for getting DNA sequencing into hospitals.
He hopes that new high-speed DNA sequencing machines will help fix that issue.
FORBES: Gleevec Inventor: Why Aren't There More Cancer Cures?
This is partly because the cost of DNA sequencing is being consumerized by both instrument innovations and the cloud.
Cancer patients may be among the first to benefit from DNA sequencing technology.
Matthew Herper has a spectacular story out this week on DNA sequencing.
The results of large-scale DNA sequencing studies of cancer genomes are very clear.
Last year we used DNA sequencing to help bring an outbreak of MRSA at Addenbrooke's hospital in Cambridge to a halt.
In the latest work, the team, from London and the University of Oxford, used DNA sequencing methods to study XMRV.
The deal would come as the cost is declining and the scientific potential is rising for DNA sequencing, experts say.
The ability to do this is remarkably enhanced when we include patient data generated with new with tools like DNA sequencing.
FORBES: Moving Healthcare from the 'Mad Men' Era into the Big Data Age
In the same breath, the article mentions DNA sequencing company Pacific Biosciences, as well as Glaukos and NeuroPace which sell medical devices.
FORBES: Why The Numbers On Health IT Venture Funding Are Confusing
In an August Forbes blog post, science writer Matthew Herper reminds us that Illumina is still the dominant force in DNA sequencing.
The chief executive of a major maker of DNA sequencing technology is talking about getting regulatory clearance to use his technology for medical purposes.
Investors are betting that, given the headway being made in DNA sequencing, it is undervalued compared to larger rivals like Illumina and Life Technologies.
The report comes amid surging interest at major cancer centers in analyzing tumor tissue with DNA sequencing and other technologies to determine customized treatments.
But competition is already hotter than many people probably expected, with other new outfits bringing forth other technologies that could make DNA sequencing even cheaper.
应用推荐